News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

Cardinal Health Launches Pyxis ParAssistT Handheld Inventory Management System
06/10/2005

SAN DIEGO, June 10, 2005 - Cardinal Health, Inc. (NYSE: CAH), the leading provider of products and services supporting the health care industry, today launched the Pyxis ParAssist™ handheld inventory management system in conjunction with the next version of its Pyxis® supply product line. 

The Pyxis ParAssist™ system helps manage inventory at remote supply locations by collecting data using handheld bar code scanners. This information is stored with data from other Pyxis® supply products, such as the Pyxis SupplyStation® secure inventory management system and the Pyxis JITrBUD™ wireless open-access inventory management system, at the Pyxis SupplyCenter™ console server. With information for all supply locations stored in one central repository, hospitals can increase inventory accuracy, refill efficiency and proactive management of par levels.

“We’ve been able to change from manual to electronic processes in par count areas, which has transformed our logistics processes,” said Scott Page, director of logistics for Oregon Health and Science University. “With the Pyxis ParAssist™ system, we reduced on-hand inventory by approximately $93,000 in the first two months and an average of 250 fewer line items per day were picked through the warehouse. We’ve also improved communication between surgery and the warehouse, increased data entry accuracy and reduced labor workload.”

“Our customers needed a solution to automate inventory processes for areas not traditionally managed by their Pyxis SupplyStation® systems,” said Dwight Winstead, president and chief operating officer of the Clinical Technologies and Services segment of Cardinal Health. “With the release of the Pyxis ParAssist™ system and the next version of our Pyxis® supply product line, hospitals can effectively manage all supplies with Pyxis® products.”

About Cardinal Health
Cardinal Health, Inc. (www.cardinalhealth.com) is the leading provider of products and services supporting the health care industry. Cardinal Health develops, manufactures, packages and markets products for patient care; develops drug-delivery technologies; distributes pharmaceuticals and medical, surgical and laboratory supplies; and offers consulting and other services that improve quality and efficiency in health care. Headquartered in Dublin, Ohio, Cardinal Health employs more than 55,000 people on six continents and produces annual revenues of more than $65 billion.
Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these uncertainties are described in Cardinal Health's Form 10-K, Form 8-K and Form 10-Q reports (including all amendments to those reports) and exhibits to those reports, and include (but are not limited to) the costs, difficulties, and uncertainties related to the integration of acquired businesses, the loss of one or more key customer or supplier relationships or changes to the terms of those relationships, changes in the distribution patterns or reimbursement rates for health-care products and/or services, the results, consequences, effects or timing of any inquiry or investigation by any regulatory authority or any legal and administrative proceedings, the impact of previously announced restatements, difficulties in opening new facilities or fully utilizing existing capacity, difficulties and uncertainties associated with business model transitions, including the conversion of margin generated from branded pharmaceutical manufacturers to non-contingent consideration, and general economic and market conditions. Cardinal Health undertakes no obligation to update or revise any forward-looking statement.

 

More Company News
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

04/07/2021

By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health

04/07/2021

Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...

03/30/2021

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields